Literature DB >> 16357175

Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node.

Virginie Carrière1, Renaud Colisson, Carine Jiguet-Jiglaire, Elisabeth Bellard, Gérard Bouche, Talal Al Saati, François Amalric, Jean-Philippe Girard, Christine M'Rini.   

Abstract

The physiologic function of the secondary lymphoid organs to recruit large numbers of naïve lymphocytes increases the probability that antigens encounter their rare, sometimes unique, specific T lymphocytes and initiate a specific immune response. In peripheral lymph nodes (LNs), this recruitment is a multistep process, initiated predominantly within the high endothelial venules (HEVs), beginning with rolling and chemokine-dependent firm adhesion of the lymphocytes on the venular endothelium surface. We report here that, in C57BL/6 mice, the recruitment of naïve lymphocytes is impaired in LNs draining a B16 melanoma tumor. Intravital microscopy analysis of the tumor-draining LNs revealed that this effect is associated with an important defect in lymphocyte adhesion in the HEVs and a progressive decrease in the expression of the LN chemokine CCL21. In parallel with these effects, the tumor up-regulated, essentially through a P-selectin-dependent mechanism, the rolling and sticking of circulating polymorphonuclear cells within the LN low-order venules where few rolling and sticking events are usually observed. These effects of the tumor were independent of the presence of metastasis into the LN and occurred as long as the tumor developed. Together, these results indicate that the tumor proximity disturbs the LN physiology by modifying the molecular, spatial, and cellular rules that usually control leukocyte-endothelium interactions into the peripheral LNs. In addition, they emphasize a new role for the low-order venules of the peripheral LNs, which compared with the HEVs, seem to be the preferential port of entry for cells linked to inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357175     DOI: 10.1158/0008-5472.CAN-05-1190

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules.

Authors:  Christine Moussion; Jean-Philippe Girard
Journal:  Nature       Date:  2011-11-13       Impact factor: 49.962

2.  Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.

Authors:  Maria I Harrell; Brian M Iritani; Alanna Ruddell
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  [Founding a "Lymph Node Metastasis" Study Group at the West German Tumor Center (WTZE)].

Authors:  M Schenck; F vom Dorp; C Boergermann; Y Busch; A Carpinteiro; B Wilker; S Keitsch; K W Schmid; M Groneberg; M Stuschke; H Ruebben; E Gulbins
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

Review 4.  The lymph node microenvironment and its role in the progression of metastatic cancer.

Authors:  Ethel R Pereira; Dennis Jones; Keehoon Jung; Timothy P Padera
Journal:  Semin Cell Dev Biol       Date:  2015-01-22       Impact factor: 7.727

Review 5.  The two faces of IL-6 in the tumor microenvironment.

Authors:  Daniel T Fisher; Michelle M Appenheimer; Sharon S Evans
Journal:  Semin Immunol       Date:  2014-03-03       Impact factor: 11.130

Review 6.  The Lymphatic System in Disease Processes and Cancer Progression.

Authors:  Timothy P Padera; Eelco F J Meijer; Lance L Munn
Journal:  Annu Rev Biomed Eng       Date:  2016-02-05       Impact factor: 9.590

7.  CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.

Authors:  Carlos Monteagudo; David Ramos; Ana Pellín-Carcelén; Rosario Gil; Robert C Callaghan; José M Martín; Vicent Alonso; Amelia Murgui; Lara Navarro; Silvia Calabuig; José Antonio López-Guerrero; Esperanza Jordá; Antonio Pellín
Journal:  Clin Exp Metastasis       Date:  2012-04-21       Impact factor: 5.150

Review 8.  Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms.

Authors:  Suzanne Eccles; Lenaic Paon; Jonathan Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

Review 9.  Intravital imaging of CD8+ T cell function in cancer.

Authors:  Thorsten R Mempel; Christian A Bauer
Journal:  Clin Exp Metastasis       Date:  2008-07-30       Impact factor: 5.150

10.  In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy.

Authors:  Fumito Ito; Trupti D Vardam; Michelle M Appenheimer; Kevin H Eng; Sandra O Gollnick; Jason B Muhitch; Sharon S Evans
Journal:  Int J Hyperthermia       Date:  2019-11       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.